Using an app to improve quality of life for patients with endometriosis
A Mobile Application as Supportive Treatment of Endometriosis: the Effect on Quality of Life and Endometriosis-associated Pain. A Randomized Controlled Trial.
This study is testing whether using an app can help improve the quality of life and reduce pain for people with endometriosis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 308 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Trial ID | NCT06821217 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the impact of an app-based intervention on the quality of life for patients with suspected or confirmed endometriosis. Participants will be divided into two groups: one using the app and a control group not using the app, over a period of six months. The study aims to assess improvements in quality of life and pain relief through questionnaires administered at the start, and after three and six months. The app is designed to provide support and resources tailored to managing endometriosis symptoms.
Who should consider this trial
Good fit: Ideal candidates are premenopausal women aged 18 and older with confirmed or suspected endometriosis who own a smartphone.
Not a fit: Patients who are planning endometriosis surgery, undergoing hormonal therapy, or are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the quality of life and pain management for patients with endometriosis.
How similar studies have performed: While app-based interventions for chronic conditions have shown promise, this specific approach for endometriosis is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed Consent as documented by signature * Age 18 or older * Premenopausal status (menopause is defined as amenorrhea lasting one year or longer) * Endometriosis, confirmed by surgery or clinically suspected * Possession of a smartphone Exclusion Criteria: * Planned endometriosis surgery or planned hormonal therapy in the study period * Surgery and/or new hormonal therapy in the last three months * Malignant diseases * Pregnancy * Breastfeeding * Active desire for pregnancy in the study period * Fertility treatment * Simultaneous participation in other intervention studies
Where this trial is running
Bern
- Department of Gynecology and Obstetrics, Women's University Hospital, Inselspital Bern, University of Bern — Bern, Switzerland (Recruiting)
Study contacts
- Principal investigator: Marietta Gulz, MD — University Hospital Bern, Insel Gruppe AG
- Study coordinator: Marietta Gulz, MD
- Email: marietta.gulz@insel.ch
- Phone: +41 31 632 10 10
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.